#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Liposarcoma Progressive multifocal leukoencephalopathy Hypereosinophilic syndrome Transitional cell cancer of the renal pelvis and ureter Progressive supranuclear palsy Pneumonia Breast angiosarcoma metastatic Squamous cell carcinoma of head and neck Waldenstrom's macroglobulinaemia Hyperchylomicronaemia Niemann-Pick disease Metastatic gastric cancer B-cell type acute leukaemia Hereditary neuropathic amyloidosis Neuroblastoma More trials…
Learn about Rare Diseases

Rhabdoid tumour – Diagnostics Niemann-Pick disease – Basic Information Ewing’s sarcoma – Diagnostics Haemophilia A with anti factor VIII – Diagnostics Focal segmental glomerulosclerosis – Basic Information Mastocytosis – Trials in Disease Castleman’s disease – Life with Disease Idiopathic inflammatory myopathy – Treatment Rhabdomyosarcoma – Life with Disease Cholangitis sclerosing More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Interferon Beta-1B Bi-1910 Rbl016.2 Chlorphenamine Maleate CEFTAROLINE FOSAMIL DCC-3084 Dactylis Glomerata Xanomeline Tartrate Tetracycline Hydrochloride Cat Epithelium Extract Etrasimod Arginine Ck-0045 Gs-5245 Ranitidine Safinamide Proline Roxadustat STREPTOCOCCUS PYOGENES Lapatinib Plitidepsin More therapies…

Learn about Your Condition

Tendon rupture Intervertebral disc protrusion Spina bifida Dysmenorrhoea Irritable bowel syndrome Vulval cancer recurrent Neurofibromatosis Bladder cancer recurrent Haemolytic uraemic syndrome Allergic respiratory disease Pancreatic carcinoma recurrent Indolent systemic mastocytosis Pelvic venous thrombosis Measles Tonsillitis More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Lung disorder

Study on the Effectiveness of Osimertinib for Patients with EGFR Mutant Non-Small Cell Lung Cancer Based on TP53 Mutation Status

Not recruiting

3 1 1 1
Investigated Diseases:
- Lung disorder
Investigated Drugs:
- Osimertinib
Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Not recruiting

3 1 1
Investigated Diseases:
- Lung disorder
Investigated Drugs:
- Baricitinib
+8
Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Not recruiting

2 1
Investigated Diseases:
- Lung disorder
Investigated Drugs:
- Bemcentinib
+4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Lung disorder

Study on the Effectiveness of Osimertinib for Patients with EGFR Mutant Non-Small Cell Lung Cancer Based on TP53 Mutation Status

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies